Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility

Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility. 2023-10-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetynoticeInternational Council for-HarmonisationICH Technical Requirementsguidance S5(R3)detection of toxicityreproduction for medicinal-productstoxicity to male-fertility Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male FertilityHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/safety/notice-ich-s5-r3-detection-toxicity-reproduction-medicinal-products-toxicity-male-fertility.html Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male FertilityHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/innocuite/avis-ich-s5-r3-detection-toxicite-reproduction-fertilite-males-produits-pharmaceutiques-destines-humains.html

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility.

Data and Resources

Similar records